Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Antiviral Res. 2010 Jul 13;88(1):38–44. doi: 10.1016/j.antiviral.2010.07.003

Figure 4.

Figure 4

Effects of combination treatment of an influenza A/NWS/33 (H1N1) virus infection with oseltamivir (0.4 mg/kg/day) and peramivir (various doses) on mouse body weights. Intramuscular treatments with peramivir and p.o. treatments with oseltamivir were given twice a day for 5 days starting 2 hours prior to virus exposure. Body weights accompany the survival data of Table 3.